breast cancer
Conditions
Interventions
Experimental group of 7 women. All patients will be submitted to TENS intervention and the pre and post intervention data for each patient will be compared. A single application of TENS will be carrie
E02.331.800
Sponsors
Faculdade de Medicina do ABC (FMABC)
Pesquisare Saúde
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Woman over 18 years; primary diagnosis confirmed by immunohistochemistry and biopsy; not having started chemotherapy.
Exclusion criteria
Exclusion criteria: Metastatic disease or bilateral breast cancer; any other malignancy in the past 5 years; biological therapy for any indication; rheumatic ot orthopedic disease; physical therapy with indication of pain or inflammation; uncontrolled cardiovascular or endocrine disease; active infection; recent major surgery
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoint 1: Analyze the size of the blood reduction effect of proinflammatory cytokines according to breast cancer immunohistochemistry;Secondary endpoint 2: Analyze the reduction of pro-inflammatory cytokines in urine;Secondary endpoint 3: Compare the blood reduction of pro-inflammatory cytokines with the reduction of cytokines in urine. | — |
Primary
| Measure | Time frame |
|---|---|
| Primary endpoint 1: Analyze the reduction in blood concentration of pro-inflammatory cytokines using the ELISA method.;Primary endpoint 2: Analyze the effect size according to each type of proinflammatory cytokine (interleukin 8, interleukin 6 interleukin 2, interleukin 1 and TNF alpha). | — |
Countries
Brazil
Contacts
Public ContactTabata Cristina do Carmo Almeida
Outcome results
None listed